5 Reasons To Buy Astex Pharmaceuticals
By Markus Aarnio:Astex Pharmaceuticals (ASTX) is a leader in innovative drug discovery, development and commercialization, and is committed to the fight against cancer and other life-threatening diseases.
I see at least 5 reasons to buy the stock currently.
1. Promising Pipeline
Astex Pharmaceuticals has established a broad pipeline of small molecule, molecularly-targeted drugs using its drug discovery engine, Pyramid, which is also used to support the company's drug discovery collaborations with leading pharmaceutical company partners.
Astex has a marketed product, Dacogen, indicated for the treatment of myelodysplastic syndromes. Dacogen is marketed by Eisai (ESALY.PK) in North America and Janssen Cilag GmbH, International, a Johnson & Johnson company (JNJ), in the rest of the world.The company's primary developmental efforts revolve around the products progressing out of their small-molecule drug discovery programs. The company's two lead internal programs are AT13387, a novel HSP 90 inhibitor, and SGI-110, a novel second generationComplete Story »